Functional decline associated with polypharmacy and potentially inappropriate medications in community-dwelling older adults with dementia

49Citations
Citations of this article
79Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This study provides empirical evidence on whether polypharmacy and potentially inappropriate prescription medications (PIRx, as defined by the 2003 Beers criteria) increase the likelihood of functional decline among community-dwelling older adults with dementia. Data were from the National Alzheimer's Coordinating Center, Uniform Data Set (9/2005-9/2009). Study sample included 1994 community-dwelling participants aged ≥65 with dementia at baseline. Results showed that participants having ≥5 medications were more likely to have functional decline than participants having <5 medications. However, the increased likelihood was only apparent in participants who did not have PIRx. Instead of magnifying the associated risk as hypothesized, PIRx appeared to have a protective effect albeit marginally statistically significant. Therefore, increased medication burden may be associated with functional decline in community-dwelling older adults with dementia who are not prescribed with PIRx. More research is needed to understand which classes of medications have the most deleterious effect on this population. © 2011 SAGE Publications.

Cite

CITATION STYLE

APA

Lau, D. T., Mercaldo, N. D., Shega, J. W., Rademaker, A., & Weintraub, S. (2011). Functional decline associated with polypharmacy and potentially inappropriate medications in community-dwelling older adults with dementia. American Journal of Alzheimer’s Disease and Other Dementias, 26(8), 606–615. https://doi.org/10.1177/1533317511432734

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free